By Frank Prenesti
Date: Thursday 23 Apr 2026
(Sharecast News) - Shares in Sanofi rose as the French pharma giant beat first-quarter sales estimates on Thursday on continuing demand for its Dupixent asthma and eczema drug just before the arrival of new chief executive Belén Garijo.
No recent information was found.
| Currency | Euro |
| Share Price | 74.14 |
| Change Today | 0.80 |
| % Change | 1.09 % |
| 52 Week High | 90.44 |
| 52 Week Low | 71.87 |
| Volume | 6,466,073 |
| Shares Issued | 1,220.40m |
| Market Cap | 90,480m |
| Beta | 0.07 |
| Strong Buy | 13 |
| Buy | 7 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

| Time | Volume / Share Price |
| 17:39 | 100 @ 74.14 |
| 17:39 | 140 @ 74.14 |
| 17:39 | 3,000 @ 74.14 |
| 17:39 | 31 @ 74.14 |
| 17:39 | 1,555 @ 74.14 |
You are here: research